Residency · Residency · General Surgery

Acute and Chronic Pancreatitis: Surgical Management

Acute Pancreatitis

Classification -- Revised Atlanta (2012)

The Revised Atlanta Classification (2012) categorizes acute pancreatitis into three severity grades:

Mild acute pancreatitis has no organ failure and no local or systemic complications. Moderately severe disease involves transient organ failure (lasting less than 48 hours) or local complications. Severe acute pancreatitis is defined by persistent organ failure lasting more than 48 hours and carries a mortality of 30 to 50%.

Etiology

Gallstones (40%) and alcohol (30%) account for the majority of cases. Other causes include hypertriglyceridemia, post-ERCP pancreatitis, drugs, autoimmune pancreatitis, and idiopathic causes. In gallstone pancreatitis, cholecystectomy during the index admission (for mild cases) or after recovery (for severe cases) is indicated to prevent recurrence.

Local Complications

The local complications of acute pancreatitis are defined by their timing, morphology, and the type of pancreatitis:

Acute peripancreatic fluid collections (APFCs) occur within 4 weeks, lack a capsule, and are associated with interstitial pancreatitis. Pancreatic pseudocysts develop after 4 weeks, are encapsulated, contain no solid component, and arise from interstitial pancreatitis. Acute necrotic collections (ANCs) appear within 4 weeks and are heterogeneous, containing both solid and liquid components from necrotizing pancreatitis. Walled-off necrosis (WON) matures after 4 weeks as encapsulated necrosis with a well-defined wall.

Initial Management

Initial management includes aggressive IV fluid resuscitation (goal-directed, with Ringer's lactate preferred), pain control using multimodal analgesia, and early enteral nutrition within 24 to 48 hours if tolerated (via nasojejunal tube if needed). Antibiotics are not indicated prophylactically and should be reserved for proven infected necrosis or extrapancreatic infections. ERCP is indicated for gallstone pancreatitis with concurrent cholangitis or persistent CBD obstruction.

<image>CT scan showing necrotizing pancreatitis with walled-off necrosis demonstrating heterogeneous collection with gas bubbles indicating infected necrosis</image>

Infected Necrotizing Pancreatitis -- Step-Up Approach

Infected necrosis should be suspected when there is clinical deterioration after initial improvement, gas within a necrotic collection on CT, or persistent sepsis. The step-up approach proceeds through escalating levels of intervention. Step 1 is percutaneous catheter drainage (CT- or US-guided), which may be definitive in 30 to 50% of patients; large-bore catheters are used and may need upsizing and placement of multiple drains. Step 2 is minimally invasive necrosectomy if drainage fails, with options including endoscopic transgastric necrosectomy (preferred if the collection abuts the stomach), video-assisted retroperitoneal debridement (VARD) through the drain tract, or laparoscopic transgastric or transperitoneal approaches. Step 3 is open surgical necrosectomy, reserved for failure of minimally invasive approaches, which carries higher morbidity and mortality. The PANTER trial (2010) and TENSION trial demonstrated the superiority of the step-up approach over primary open necrosectomy. Whenever possible, intervention should be delayed to at least 4 weeks to allow demarcation of necrosis and maturation of the wall.

Endoscopic Ultrasound (EUS)-Guided Drainage

Lumen-apposing metal stents (LAMS) are used for transgastric drainage of walled-off necrosis and allow endoscopic necrosectomy through the stent lumen. The MISER trial showed that the endoscopic approach was associated with lower morbidity than the surgical approach.

Vascular Complications

Vascular complications of acute pancreatitis include pseudoaneurysm formation (involving the splenic, gastroduodenal, or pancreaticoduodenal arteries), managed with angiographic embolization. Splenic vein thrombosis leads to left-sided portal hypertension and gastric varices. Portal or mesenteric vein thrombosis is managed with anticoagulation if acute.

<image>Step-up approach algorithm for infected necrotizing pancreatitis showing progression from percutaneous drainage to minimally invasive necrosectomy to open necrosectomy</image>

Gallstone Pancreatitis -- Surgical Considerations

Cholecystectomy during the index admission for mild gallstone pancreatitis reduces readmission for recurrent biliary events. Intraoperative cholangiography or preoperative MRCP should be performed to evaluate for CBD stones. ERCP is reserved for confirmed choledocholithiasis or cholangitis. For severe necrotizing pancreatitis, cholecystectomy is delayed until collections resolve, typically 6 or more weeks.

Pancreatic Pseudocyst

Most pancreatic pseudocysts resolve spontaneously, and intervention is reserved for symptomatic cysts, those exceeding 6 cm (a relative indication), or those with complications (infection, hemorrhage, or obstruction). Endoscopic EUS-guided cystogastrostomy is the preferred drainage method. Surgical options include cystogastrostomy or cystojejunostomy (Roux-en-Y). Percutaneous drainage is used when endoscopic or surgical drainage is not feasible. It is essential to ensure the absence of solid components before drainage -- if solid debris is present, the collection represents walled-off necrosis, not a pseudocyst.

Chronic Pancreatitis

Etiology and Pathophysiology

The most common cause in Western countries is alcohol, with other etiologies including genetic mutations (PRSS1, SPINK1, CFTR), autoimmune, obstructive, and tropical causes. The disease involves progressive fibrosis and destruction of both exocrine and endocrine function. Pain is the dominant symptom, and its mechanism is multifactorial, involving ductal hypertension, neural inflammation, and central sensitization.

Diagnosis

CT may show calcifications, a dilated pancreatic duct, and parenchymal atrophy. MRCP (or secretin-enhanced MRCP) evaluates ductal morphology and side branch changes. EUS applies the Rosemont criteria for diagnosing early chronic pancreatitis. Pancreatic function tests include fecal elastase-1 (values less than 200 mcg/g indicate exocrine insufficiency) and 72-hour fecal fat quantification.

Medical Management

Medical management follows an analgesic ladder while avoiding opioid dependence. Pancreatic enzyme replacement therapy (PERT) is prescribed for exocrine insufficiency. Fat-soluble vitamin supplementation (A, D, E, K) is necessary. Diabetes management requires particular attention because these patients develop brittle diabetes with risk of hypoglycemia due to loss of glucagon. Alcohol and smoking cessation slow disease progression.

Endoscopic Therapy

ERCP with pancreatic duct stenting and stone extraction (with ESWL for large stones) is useful for dominant strictures in the head of the pancreatic duct. However, endoscopic therapy is inferior to surgery for long-term pain relief, as demonstrated by multiple randomized controlled trials.

<image>MRCP showing dilated pancreatic duct with chain-of-lakes appearance and intraductal calculi characteristic of chronic pancreatitis</image>

Surgical Options for Chronic Pancreatitis

Drainage Procedures (for Dilated Duct >7 mm)

The lateral pancreaticojejunostomy (Puestow/Partington-Rochelle) opens the pancreatic duct longitudinally and anastomoses it to a Roux-en-Y jejunal limb. It achieves pain relief in 70 to 80% of patients with low morbidity and preserves pancreatic parenchyma. It is best suited for "large duct" disease with multiple strictures.

Resection Procedures

Pancreaticoduodenectomy (Whipple) is indicated for disease predominantly in the head of the pancreas and provides effective pain relief in 70 to 90% of patients, though with higher morbidity. The pylorus-preserving modification is most commonly used. Distal pancreatectomy (with or without splenectomy) is appropriate for tail-predominant disease, with spleen-preserving techniques (Warshaw or Kimura) employed when possible. The Beger procedure (duodenum-preserving pancreatic head resection) involves subtotal resection of the pancreatic head while preserving the duodenum, maintaining GI continuity and resulting in a lower rate of dumping. The Frey procedure (local resection of the head combined with lateral pancreaticojejunostomy) combines coring out of the pancreatic head with longitudinal duct drainage and is the most versatile procedure for combined large duct and head-predominant disease. It is less technically demanding than the Beger procedure with similar outcomes. The Hamburg modification of the Beger procedure involves complete transection of the neck with separate drainage of both the head and body/tail remnants.

Total Pancreatectomy with Islet Autotransplantation (TPIAT)

TPIAT is considered for diffuse small-duct disease, failed prior operations, or genetic pancreatitis. The total pancreatectomy removes the source of pain, while islet cell isolation and hepatic portal vein infusion aim to preserve some endogenous insulin production. Approximately 30% of patients remain insulin-independent, and 90% experience improved pain. Best outcomes are achieved in younger patients without prior pancreatic surgery.

Choice of Operation

For large duct disease (duct greater than 7 mm), the Frey or Puestow procedure is appropriate. For an inflammatory mass in the head, the Frey, Beger, or Whipple procedure is indicated. For small duct, diffuse disease, TPIAT should be considered. For tail-predominant disease, distal pancreatectomy is performed. Surgery is superior to endoscopic therapy for long-term pain relief, as demonstrated by Cahen et al. in the New England Journal of Medicine (2007).

<image>Operative diagram of the Frey procedure showing coring of the pancreatic head combined with longitudinal pancreaticojejunostomy to a Roux-en-Y limb</image>

Clinical Pearls

In acute pancreatitis, the key question for the surgeon is whether the etiology is gallstones -- if so, cholecystectomy during the index admission for mild disease prevents recurrence. The step-up approach has revolutionized the management of necrotizing pancreatitis, and intervention should be delayed to 4 weeks if possible rather than rushing to necrosectomy. Gas in a necrotic collection on CT does not always indicate infection; fine-needle aspiration for Gram stain and culture should be performed to confirm if the clinical picture is equivocal. For chronic pancreatitis, the Frey procedure is the most versatile option for combined head and duct disease. Endocrine and exocrine insufficiency are inevitable long-term consequences, and patients should be counseled about lifelong enzyme replacement and potential diabetes. Chronic pancreatitis is a risk factor for pancreatic cancer (4 to 7% lifetime risk), and surveillance should be maintained with a low threshold for biopsy of any new mass lesion.

References

• Banks PA, et al. Classification of acute pancreatitis -- 2012: revision of the Atlanta classification. Gut. 2013;62(1):102-111.
• van Santvoort HC, et al. A step-up approach or open necrosectomy for necrotizing pancreatitis (PANTER). N Engl J Med. 2010;362(16):1491-1502.
• van Brunschot S, et al. Endoscopic or surgical step-up approach for infected necrotising pancreatitis (TENSION). Lancet. 2018;391(10115):51-58.
• Cahen DL, et al. Endoscopic versus surgical drainage of the pancreatic duct in chronic pancreatitis. N Engl J Med. 2007;356(7):676-684.
• Bellin MD, et al. Total pancreatectomy and islet autotransplantation. Pancreas. 2016;45(1):8-15.

Read this lecture as Markdown